Turning Point Brands (NYSE: TPB) reported Q3 EPS of $1.27, $0.49 better than the analyst estimate of $0.78. Revenue for the quarter came in at $119 million versus the consensus estimate of $111.43 million.

2025 Outlook

The Company is increasing full-year 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million (from $110.0 – 114.0 million) and projected full-year 2025 Modern Oral sales to $125.0 – 130.0 million (from $100.0 – 110.0 million).

For earnings history and earnings-related data on Turning Point Brands (TPB) click here.